ResMed Inc. (LON:0KW4)

ResMed Ratios and Metrics

Market cap in millions GBP. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	27,429	27,563	22,248	25,286	25,257	25,996
Market Cap Growth	-2.06%	23.89%	-12.02%	0.11%	-2.84%	15.88%
Enterprise Value	27,014	27,486	22,966	26,454	25,761	26,440
Last Close Price	183.98	186.48	149.04	168.25	169.59	171.90
PE Ratio	24.85	26.96	27.54	35.80	39.38	75.67
PS Ratio	6.84	7.34	6.00	7.61	8.58	11.23
PB Ratio	5.84	6.33	5.78	7.78	9.13	12.44
P/TBV Ratio	12.97	15.37	18.30	39.81	28.46	63.52
P/FCF Ratio	20.61	22.73	21.60	56.02	141.88	56.63
P/OCF Ratio	19.28	21.56	20.07	46.35	87.40	48.73
EV/Sales Ratio	6.87	7.32	6.20	7.96	8.75	11.42
EV/EBITDA Ratio	17.92	20.24	18.93	26.02	27.80	35.49
EV/EBIT Ratio	20.03	22.32	20.97	29.18	31.24	39.80
EV/FCF Ratio	20.29	22.66	22.30	58.60	144.71	57.60
Debt / Equity Ratio	0.13	0.14	0.18	0.38	0.27	0.28
Debt / EBITDA Ratio	0.41	0.45	0.56	1.19	0.79	0.75
Debt / FCF Ratio	0.47	0.51	0.67	2.75	4.24	1.25
Asset Turnover	0.69	0.68	0.69	0.71	0.73	0.69
Inventory Turnover	2.15	2.09	1.87	1.84	2.30	2.97
Quick Ratio	1.97	2.16	1.22	1.23	1.28	1.01
Current Ratio	3.06	3.44	2.59	3.12	2.80	1.73
Return on Equity (ROE)	25.68%	25.86%	22.70%	23.96%	24.96%	17.63%
Return on Assets (ROA)	14.74%	14.02%	12.70%	12.15%	12.75%	12.31%
Return on Invested Capital (ROIC)	26.60%	25.36%	20.35%	19.81%	22.04%	14.67%
Return on Capital Employed (ROCE)	25.40%	23.60%	23.20%	19.20%	22.70%	24.00%
Earnings Yield	4.02%	3.71%	3.63%	2.79%	2.54%	1.32%
FCF Yield	4.85%	4.40%	4.63%	1.79%	0.70%	1.77%
Dividend Yield	0.68%	0.83%	1.02%	0.82%	0.81%	0.67%
Payout Ratio	22.88%	22.19%	27.65%	28.78%	31.48%	47.78%
Buyback Yield / Dilution	0.43%	0.14%	-0.06%	-0.28%	-0.40%	-0.55%
Total Shareholder Return	1.11%	0.97%	0.95%	0.54%	0.41%	0.12%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.